Scripsamerica EBITDA 2013-2015 | SCRCQ

Scripsamerica ebitda from 2013 to 2015. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Scripsamerica Annual EBITDA
(Millions of US $)
2014 $-4
2013 $-7
2012 $-2
Scripsamerica Quarterly EBITDA
(Millions of US $)
2015-03-31 $-1
2014-12-31
2014-09-30 $2
2014-03-31 $0
2013-12-31
2013-09-30 $-3
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs. The Company is focused on pharmaceutical supply chain management services, from strategic sourcing to delivering niche generic pharmaceuticals to market. It delivers pharmaceutical products to a range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The Company's therapeutic categories include pain, arthritis, prenatal, urinary and hormonal replacement drugs. ScripsAmerica, Inc. is based in Tysons Corner, Virginia.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $85.018B 20.42
Becton Dickinson (BDX) United States $56.007B 13.69
Cardinal Health (CAH) United States $35.638B 18.11
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
West Pharmaceutical Services (WST) United States $17.687B 35.34
Cooper (COO) United States $14.820B 18.43
Align Technology (ALGN) United States $10.292B 20.28
Henry Schein (HSIC) United States $8.365B 14.80
Merit Medical Systems (MMSI) United States $5.377B 25.94
DENTSPLY SIRONA (XRAY) United States $2.859B 8.38
CONMED (CNMD) United States $1.685B 12.12
STAAR Surgical (STAA) United States $1.363B 0.00
Lifevantage (LFVN) United States $0.169B 17.42
Pro-Dex (PDEX) United States $0.148B 16.25